BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 9133776)

  • 1. Towards a revised nomenclature for P1 and P2 receptors.
    Fredholm BB; Abbracchio MP; Burnstock G; Dubyak GR; Harden TK; Jacobson KA; Schwabe U; Williams M
    Trends Pharmacol Sci; 1997 Mar; 18(3):79-82. PubMed ID: 9133776
    [No Abstract]   [Full Text] [Related]  

  • 2. Nomenclature and classification of purinoceptors.
    Fredholm BB; Abbracchio MP; Burnstock G; Daly JW; Harden TK; Jacobson KA; Leff P; Williams M
    Pharmacol Rev; 1994 Jun; 46(2):143-56. PubMed ID: 7938164
    [No Abstract]   [Full Text] [Related]  

  • 3. Receptors for adenine nucleotides and nucleosides: subclassification, distribution, and molecular characterization.
    Dalziel HH; Westfall DP
    Pharmacol Rev; 1994 Dec; 46(4):449-66. PubMed ID: 7899473
    [No Abstract]   [Full Text] [Related]  

  • 4. Purinergic receptors.
    Malec D
    Pol J Pharmacol; 1996; 48(5):457-65. PubMed ID: 9112687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The past, present and future of purine nucleotides as signalling molecules.
    Burnstock G
    Neuropharmacology; 1997 Sep; 36(9):1127-39. PubMed ID: 9364468
    [No Abstract]   [Full Text] [Related]  

  • 6. Purinoceptors in the nervous system.
    Fredholm BB
    Pharmacol Toxicol; 1995 Apr; 76(4):228-39. PubMed ID: 7617551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitogenic signaling from P1 and P2 purinergic receptors to mitogen-activated protein kinase in human fetal astrocyte cultures.
    Neary JT; McCarthy M; Kang Y; Zuniga S
    Neurosci Lett; 1998 Feb; 242(3):159-62. PubMed ID: 9530930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. International union of pharmacology. XXIV. Current status of the nomenclature and properties of P2X receptors and their subunits.
    Khakh BS; Burnstock G; Kennedy C; King BF; North RA; Séguéla P; Voigt M; Humphrey PP
    Pharmacol Rev; 2001 Mar; 53(1):107-18. PubMed ID: 11171941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purinoceptors: are there families of P2X and P2Y purinoceptors?
    Abbracchio MP; Burnstock G
    Pharmacol Ther; 1994; 64(3):445-75. PubMed ID: 7724657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors.
    Fredholm BB; IJzerman AP; Jacobson KA; Klotz KN; Linden J
    Pharmacol Rev; 2001 Dec; 53(4):527-52. PubMed ID: 11734617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ribose modified nucleosides and nucleotides as ligands for purine receptors.
    Jacobson KA; Ravi RG; Nandanan E; Kim HS; Moro S; Kim YC; Lee K; Barak D; Marquez VE; Ji XD
    Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):333-41. PubMed ID: 11563046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purinergic P2 Receptors: Structure and Function 2.0.
    Zemkova H
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of ectoenzymes on p2 and p1 receptor signaling.
    Kukulski F; Lévesque SA; Sévigny J
    Adv Pharmacol; 2011; 61():263-99. PubMed ID: 21586362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purines '96.
    Alexander SP; Ford AP
    Trends Pharmacol Sci; 1996 Nov; 17(11):385-8. PubMed ID: 8990951
    [No Abstract]   [Full Text] [Related]  

  • 15. Purinergic receptors in microglia: functional modal shifts of microglia mediated by P2 and P1 receptors.
    Koizumi S; Ohsawa K; Inoue K; Kohsaka S
    Glia; 2013 Jan; 61(1):47-54. PubMed ID: 22674620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of extracellular ATP and P1 and P2 classes of purinergic receptors in T-cell development and cytotoxic T lymphocyte effector functions.
    Apasov S; Koshiba M; Redegeld F; Sitkovsky MV
    Immunol Rev; 1995 Aug; 146():5-19. PubMed ID: 7493760
    [No Abstract]   [Full Text] [Related]  

  • 17. P2-purinergic receptors: subtype-associated signaling responses and structure.
    Harden TK; Boyer JL; Nicholas RA
    Annu Rev Pharmacol Toxicol; 1995; 35():541-79. PubMed ID: 7598506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of purinergic signaling in cardiovascular diseases.
    Ralevic V; Burnstock G
    Drug News Perspect; 2003 Apr; 16(3):133-40. PubMed ID: 12819811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New heterocyclic ligands for the adenosine receptors P1 and for the ATP receptors P2.
    Baraldi PG; Romagnoli R; Tabrizi MA; Bovero A; Preti D; Fruttarolo F; Moorman AR; Borea PA
    Farmaco; 2005 Mar; 60(3):185-202. PubMed ID: 15784237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P1-/P2-purinergic receptors on cultured rabbit retinal Müller cells.
    Liu Y; Wakakura M
    Jpn J Ophthalmol; 1998; 42(1):33-40. PubMed ID: 9507363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.